These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 28077266)

  • 1. ASP0028 in combination with suboptimal-dose of tacrolimus in Cynomolgus monkey renal transplantation model.
    Dun H; Song L; Ma A; Hu Y; Zeng L; Bai J; Zhang G; Zhang L; Koide K; Okada Y; Hanaoka K; Yamamoto R; Hirose J; Morokata T; Daloze P; Chen H
    Transpl Immunol; 2017 Feb; 40():57-65. PubMed ID: 28077266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy.
    Kamburova EG; Koenen HJ; van den Hoogen MW; Baas MC; Joosten I; Hilbrands LB
    PLoS One; 2014; 9(11):e112658. PubMed ID: 25393622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASP1126, a Novel Sphingosine-1-Phosphate-Selective Agonist With a Favorable Safety Profile, Prolongs Allograft Survival in Rats and Nonhuman Primates in Combination With Tacrolimus With a Broad Safety Margin for Bradycardia.
    Okimoto A; Yamamoto R; Hirose J; Shimatani K; Koshika T; Maeda M; Hattori K; Morokata T
    Transplant Proc; 2019; 51(6):2081-2098. PubMed ID: 31399186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or in combination with cyclosporine or RAD.
    Schuurman HJ; Menninger K; Audet M; Kunkler A; Maurer C; Vedrine C; Bernhard M; Gaschen L; Brinkmann V; Quesniaux V
    Transplantation; 2002 Oct; 74(7):951-60. PubMed ID: 12394836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin or tacrolimus alone fails to resist cardiac allograft accelerated rejection mediated by alloreactive CD4(+) memory T cells in mice.
    Liang H; Liao C; Qi Z; Sha C; Xie B; Chen J; Xia J; Wang Y; Yao Q; Zhao Y
    Transpl Immunol; 2010 Feb; 22(3-4):128-36. PubMed ID: 19755159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of FTY720 on peripheral blood lymphocytes and graft infiltrating cells in a rat model of chronic renal allograft rejection.
    Koch M; Poehnert D; Nashan B
    Transpl Immunol; 2016 Mar; 35():12-7. PubMed ID: 26802360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of novel PKCθ selective inhibitor AS2521780 on acute rejection in rat and non-human primate models of transplantation.
    Fukahori H; Chida N; Maeda M; Tasaki M; Kawashima T; Noto T; Tsujimoto S; Nakamura K; Oshima S; Hirose J; Higashi Y; Morokata T
    Int Immunopharmacol; 2015 Aug; 27(2):232-7. PubMed ID: 26122135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of oral treatment with tacrolimus in the renal transplant model in cynomolgus monkeys.
    Kinugasa F; Nagatomi I; Ishikawa H; Nakanishi T; Maeda M; Hirose J; Fukahori H; Ooshima S; Noto T; Higashi Y; Seki N; Mutoh S
    J Pharmacol Sci; 2008 Dec; 108(4):529-34. PubMed ID: 19098392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of peritransplant FTY720 alone or in combination with post-transplant tacrolimus in a rat model of cardiac allotransplantation.
    Xu M; Pirenne J; Antoniou EA; Afford SC; D'Silva M; McMaster P
    Transpl Int; 1998; 11(4):288-94. PubMed ID: 9704394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological monitoring of renal transplant recipients to predict acute allograft rejection following the discontinuation of tacrolimus.
    Kreijveld E; Koenen HJ; van Cranenbroek B; van Rijssen E; Joosten I; Hilbrands LB
    PLoS One; 2008 Jul; 3(7):e2711. PubMed ID: 18628993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T Cell Infusion Can Enhance Memory T Cell and Alloantibody Responses in Lymphodepleted Nonhuman Primate Heart Allograft Recipients.
    Ezzelarab MB; Zhang H; Guo H; Lu L; Zahorchak AF; Wiseman RW; Nalesnik MA; Bhama JK; Cooper DK; Thomson AW
    Am J Transplant; 2016 Jul; 16(7):1999-2015. PubMed ID: 26700196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTY720 combined with tacrolimus in de novo renal transplantation: 1-year, multicenter, open-label randomized study.
    Hoitsma AJ; Woodle ES; Abramowicz D; Proot P; Vanrenterghem Y;
    Nephrol Dial Transplant; 2011 Nov; 26(11):3802-5. PubMed ID: 21911597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The JAK3 inhibitor CP-690550 selectively reduces NK and CD8+ cell numbers in cynomolgus monkey blood following chronic oral dosing.
    Conklyn M; Andresen C; Changelian P; Kudlacz E
    J Leukoc Biol; 2004 Dec; 76(6):1248-55. PubMed ID: 15371489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTY720 prolongs clear corneal allograft survival with a differential effect on different lymphocyte populations.
    Mayer K; Birnbaum F; Reinhard T; Reis A; Braunstein S; Claas F; Sundmacher R
    Br J Ophthalmol; 2004 Jul; 88(7):915-9. PubMed ID: 15205237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy of malononitrilamide FK778 with tacrolimus on cell proliferation assays and in rats receiving renal allografts.
    Vu MD; Qi S; Wang X; Jiang W; Ma A; Xu D; Bekersky I; Fitzsimmons WE; Wu J; Chen H
    Transplantation; 2003 May; 75(9):1455-9. PubMed ID: 12792496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment effects of fingolimod in multiple sclerosis: Selective changes in peripheral blood lymphocyte subsets.
    Hjorth M; Dandu N; Mellergård J
    PLoS One; 2020; 15(2):e0228380. PubMed ID: 32012202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of alemtuzumab on regulatory and memory T-cell subsets in kidney transplantation.
    Macedo C; Walters JT; Orkis EA; Isse K; Elinoff BD; Fedorek SP; McMichael JM; Chalasani G; Randhawa P; Demetris AJ; Zeevi A; Tan H; Shapiro R; Landsittel D; Lakkis FG; Metes D
    Transplantation; 2012 Apr; 93(8):813-21. PubMed ID: 22343334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a novel immunosuppressant, FTY720, on allograft survival after renal transplant in rats.
    Ueda H; Takahara S; Azuma H; Kusaka M; Suzuki S; Katsuoka Y
    Eur Surg Res; 2000; 32(5):279-83. PubMed ID: 11111172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
    Chiba K
    Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.